BNP Paribas Financial Markets’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.9K | Buy |
|
|||||
|
2025
Q2 | $14.3K | Buy |
|
|||||
|
2025
Q1 | $13.4K | Sell |
|
|||||
|
2024
Q4 | $29.5K | Sell |
|
|||||
|
2024
Q3 | $26.6K | Buy |
|
|||||
|
2024
Q2 | $20K | Sell |
|
|||||
|
2024
Q1 | $38.4K | Buy |
|
|||||
|
2023
Q4 | $23.6K | Buy |
|
|||||
|
2023
Q3 | $33.1K | Buy |
|
|||||
|
2023
Q2 | $34K | Buy |
|
|||||
|
2023
Q1 | $1.77K | Sell |
|
|||||
|
2022
Q4 | $1.73K | Buy |
|
|||||
|
2022
Q3 | $1.15K | Sell |
|
|||||
|
2022
Q2 | $46.2K | Sell |
|
|||||
|
2022
Q1 | $401K | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $95.7K | Buy |
|
|||||
|
2021
Q2 | $30.3K | Sell |
|
|||||
|
2021
Q1 | $81.2K | Buy |
|
|||||
|
2020
Q4 | $39.1K | Sell |
|
|||||
|
2020
Q3 | $40.6K | Buy |
|
|||||
|
2020
Q2 | $7.23K | Buy |
|
|||||
|
2020
Q1 | $87 | Hold |
|
|||||
|
2019
Q4 | $86 | Sell |
|
|||||
|
2019
Q3 | $6.65K | Hold |
|
|||||
|
2019
Q2 | $6.8K | Sell |
|
|||||
|
2019
Q1 | $17.6K | Buy |
|
|||||
|
2018
Q4 | $801 | Sell |
|
|||||
|
2018
Q3 | $8.89K | Sell |
|
|||||
|
2018
Q2 | $8.15K | Sell |
|
|||||
|
2018
Q1 | $31.8K | Buy |
|
|||||
|
2017
Q4 | $28.6K | Buy |
|
|||||
|
2017
Q3 | $43.1K | Buy |
|
|||||
|
2017
Q2 | $24.2K | Buy |
|
|||||
|
2017
Q1 | $788 | Sell |
|
|||||
|
2016
Q4 | $5.11K | Buy |
|
|||||
|
2016
Q3 | $2.61K | Buy |
|